???global.info.a_carregar???
Adriana Albini was born in Venice (I) and works in Milan. Married, with two children. She is the Director of Laboratory of the Vascular Biology and Angiogenesis Laboratory of IRCCS MultiMedica, Sesto San Giovanni-Milano and Scientific Director of Fondazione MultiMedica Onlus, Milan. From April 2012 to August 2015 she was the Director of the Department ¿Research and Statistics Infrastructure¿ (I-RS) and Director of the Translational Research Laboratory at the IRCCS ¿Tecnologie Avanzate e Modelli Assistenziali in Oncologia¿ - Arcispedale S. Maria Nuova - Reggio Emilia She has been President of the Italian Society for Cancer Research (SIC) and President of Metastasis Research Society (MRS). From 2009 at 2012 she was Scientific Director of MultiMedica Medical Center Castellanza (VA), Italy. From 2006 at 2012 she was the Head of Oncology Research at Fondazione MultiMedica Onlus, Milan From January 2005 to September 2006 she was Director of the Department of Traslational Oncology. From June 2004 to September 2006 she was Deputy Chief of Intramural Research, National Institute for Research on Cancer, Genoa (IST). From 1999 to september 2006 Dr. A. Albini was the head of Laboratory of Molecular Oncology. From 1986 to 1996 she was deputy chief in the Department of Chemical Carcinogenesis (National Institute for Cancer Research) where in 1996 she became chief of the section ¿Mechanisms of Tumor progression¿. She has a Ph.D in Chemistry and trained from 1985 to 1987 as a postdoctoral fellow at Max-Planck Institute for Biochemistry, Martinsried bei Muenchen , Germany. She is member of editorial boards of scientific journals: Carcinogenesis, Cancer Research, Journal of the National Cancer Institute. She is Member of Scientific Council AIRC_Italian Association for Cancer Research, Member of Panel L4 ERC Consolidator Grants and Evaluator for MIUR-Ministery of University and Instruction of Italy. She is member of the Scientific Council of ONDA (National Observatory on Women's Health) and of the Scientific Council of ESO (European School of Oncology). Dr. Albini received various scientific awards. She has over 350 scientific publications in peer review journals. She is among the most cited Italian women scientists with highest h Index (a measure of citations), of 77 (Scopus). Her major focus is tumor microenvironment in vitro and in vivo models for angiogenesis and inflammation, mechanisms of invasion of tumor and endothelial cells. Her most recent interest is anti-angiogenesis in a chemopreventive setting. She developed major assays in invasion and angiogenesis and has numerous patents in the field. She is active as scientific journalist and novel writer.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Adriana Albini

Nomes de citação

  • Albini, Adriana

Identificadores de autor

Ciência ID
891C-7278-F83C
ORCID iD
0000-0002-9624-5103

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Oncologia
  • Ciências Médicas e da Saúde - Ciências da Saúde - Nutrição e Dietética
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2015/01/01 - Atual Investigador Coordenador (carreira) (Investigação) IRCCS MultiMedica, Itália

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2018/03/01 - Atual Professor Catedrático (Docente Universitário) Università degli Studi di Milano-Bicocca Dipartimento di Medicina e Chirurgia, Itália
Projetos

Bolsa

Designação Financiadores
2016 - 2016 Conto Capitale 2016
2365500
 Ministero della Salute
1999 - 2004 "Proprietà molecolari e biologiche della proteina codificata da HIV-Tat. Esame della struttura e funzioni di Tat come nuovo bersaglio di strategie terapeutiche"
EUR 118.785,000 (2002)
40C.4 ITL 230.000.000,00 (1999)
EUR 60.000,00 (2004)
 Istituto Superiore di Sanità
1997 - 1998 "Proprietà molecolari e biologiche della proteina codificata da HIV-Tat. Esame della struttura e funzioni di Tat come nuovo bersaglio di strategie terapeutiche"
40B.4 ITL 250.000.000 (1998)
40A.0.3 ITL 250.000.000 (1997)
 ISS - Istituto Superiore di Sanità
1995 - 1996 "Funzione dei componenti della matrice extracellulare dei tumori nei processi angiogenici. Nuovi possibili targets terapeutici Coven."
ICS070.1RF95/217
 Ministero della Salute
1995 - 1995 "Modelli in vitro ed in vivo per lo studio dell'eziopatogenesi del Sarcoma di Kaposi
9304-03
 Istituto Superiore di Sanità
1990 - 1993 "Studi sulla proteina Tat di HIV"
6206.002 ITL 115,000,000.00 (1991)
5206.002 ITL 50,000,000.00 (1990)
7204.002 ITL 115,000,000.00 (1992)
8204.02 ITL 120,000,000.00 (1993)
 Istituto Superiore di Sanità
1989 - 1990 "Inibizione selettiva di proprietà "in vitro" collegate al fenotipo metastaico "in vivo"
n.86.00621.44
 Consiglio Nazionale delle Ricerche

Projeto

Designação Financiadores
1994 - 1994 "Studi sulla proteina Tat di HIV"
9204.03
 Istituto Superiore di Sanità
Produções

Publicações

Artigo em revista
  1. Clementina Sansone; Antonino Bruno; Concetta Piscitelli; Denisa Baci; Fontana A.; Christophe Brunet; Douglas M. Noonan; Adriana Albini. "Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy". Cells (2021): https://www.mdpi.com/2073-4409/10/2/231.
    10.3390/cells10020231
  2. Marco Festa; Clementina Sansone; Christophe Brunet; Fabio Crocetta; Luisa Di Paola; Michele Lombardo; Antonino Bruno; Douglas Noonan; Adriana Albini. "Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection". International Journal of Molecular Sciences (2020): https://www.mdpi.com/1422-0067/21/21/8364.
    10.3390/ijms21218364
  3. Grazia Caci; Adriana Albini; Mario MALERBA; Douglas Noonan; Patrizia Pochetti; Riccardo POLOSA. "COVID-19 and Obesity: Dangerous Liaisons". Journal of Clinical Medicine (2020): https://www.mdpi.com/2077-0383/9/8/2511.
    10.3390/jcm9082511
  4. Silvia Bombelli; Chiara Meregalli; Chiara Grasselli; Maddalena M. Bolognesi; Antonino Bruno; Stefano Eriani; Barbara Torsello; et al. "PKHhigh/CD133+/CD24- Renal Stem-Like Cells Isolated from Human Nephrospheres Exhibit In Vitro Multipotency". Cells (2020): https://www.mdpi.com/2073-4409/9/8/1805.
    10.3390/cells9081805
  5. Albini, Adriana. "Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients". Cardiovascular Toxicology (2020): http://dx.doi.org/10.1007/s12012-020-09583-5.
    10.1007/s12012-020-09583-5
  6. Albini, Adriana. "The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies". Internal and Emergency Medicine (2020): http://dx.doi.org/10.1007/s11739-020-02364-6.
    10.1007/s11739-020-02364-6
  7. Albini, Adriana. "Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases". Antioxidants (2020): http://dx.doi.org/10.3390/antiox9050392.
    10.3390/antiox9050392
  8. Albini, Adriana. "Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface". Frontiers in Oncology (2020): http://dx.doi.org/10.3389/fonc.2020.00156.
    10.3389/fonc.2020.00156
  9. Matteo Gallazzi; Marco Festa; Paola Corradino; Clementina Sansone; Adriana Albini; Douglas M. Noonan. "An Extract of Olive Mill Wastewater Downregulates Growth, Adhesion and Invasion Pathways in Lung Cancer Cells: Involvement of CXCR4.". Nutrients (2020): https://www.mdpi.com/2072-6643/12/4/903.
    10.3390/nu12040903
  10. Albini, Adriana. "Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.". Journal of experimental & clinical cancer research : CR (2019): https://europepmc.org/articles/PMC6852951.
    10.1186/s13046-019-1461-z
  11. Albini, Adriana. "Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene.". Frontiers in Immunology (2019): https://europepmc.org/articles/PMC6848152.
    10.3389/fimmu.2019.02587
  12. Albini, Adriana. "Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception.". Nutrients (2019): https://europepmc.org/articles/PMC6627306.
    10.3390/nu11061226
  13. Albini, Adriana. "Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.". Frontiers in Immunology (2019): https://europepmc.org/articles/PMC6482162.
    10.3389/fimmu.2019.00771
  14. Albini, Adriana. "Recent advances in the molecular landscape of lung neuroendocrine tumors.". Expert review of molecular diagnostics (2019): https://doi.org/10.1080/14737159.2019.1595593.
    10.1080/14737159.2019.1595593
  15. Albini, Adriana. "Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater". International Journal of Molecular Sciences (2019): http://dx.doi.org/10.3390/ijms20020307.
    10.3390/ijms20020307
  16. Albini, Adriana. "Prophylaxis of Non-communicable Diseases: Why Fruits and Vegetables may be Better Chemopreventive Agents than Dietary Supplements Based on Isolated Phytochemicals?". Current pharmaceutical design (2019): https://doi.org/10.2174/1381612825666190702093301.
    10.2174/1381612825666190702093301
  17. Albini, Adriana. "Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.". Clinical pathology (Thousand Oaks, Ventura County, Calif.) (2019): https://europepmc.org/articles/PMC6477754.
    10.1177/2632010X19829259
  18. Albini, Adriana. "Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.". J Thorac Oncol. (2018):
  19. Pelosi G; Bianchi F; Dama E; Simbolo M; Mafficini A; Sonzogni A; Pilotto S; et al. "Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.". Virchows Archiv : an international journal of pathology (2018): http://europepmc.org/abstract/med/29388013.
    10.1007/s00428-018-2307-3
  20. Baci D; Bruno A; Bassani B; Tramacere M; Mortara L; Albini A; Noonan DM. "Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.". Cancer letters (2018): http://europepmc.org/abstract/med/29678548.
    10.1016/j.canlet.2018.04.018
  21. Grasso S; Chapelle J; Salemme V; Aramu S; Russo I; Vitale N; di Cantogno LV; et al. "Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.". Nature communications (2018): http://europepmc.org/abstract/med/29600801.
    10.1038/ncomms16203
  22. D'Uva G; Baci D; Albini A; Noonan DM. "Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.". Cancer treatment reviews (2018): http://europepmc.org/abstract/med/29197745.
    10.1016/j.ctrv.2017.10.013
  23. Albini A; Gallo M. "What the oncologist can learn from diabetes studies: Epidemiology, prevention, management, cure.". Diabetes research and clinical practice (2018): http://europepmc.org/abstract/med/29410239.
    10.1016/j.diabres.2018.01.026
  24. Bosi A; Zanellato S; Bassani B; Albini A; Musco A; Cattoni M; Desio M; et al. "Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.". Journal of immunology research (2018): http://europepmc.org/abstract/med/29713652.
    10.1155/2018/2438598
  25. Albini A; Bruno A; Bassani B; D'Ambrosio G; Pelosi G; Consonni P; Castellani L; et al. "Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach.". Frontiers in Endocrinology (2018): http://europepmc.org/abstract/med/29674995.
    10.3389/fendo.2018.00110
  26. Albini A; Bruno A; Noonan DM; Mortara L. "Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.". Frontiers in immunology (2018): http://europepmc.org/abstract/med/29675018.
    10.3389/fimmu.2018.00527
  27. Pelosi G; Sonzogni A; Harari S; Albini A; Bresaola E; Marchiò C; Massa F; et al. "Classification of pulmonary neuroendocrine tumors: new insights.". Translational lung cancer research (2017): http://europepmc.org/abstract/med/29114468.
    10.21037/tlcr.2017.09.04
  28. Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; et al. "Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.". European journal of medicinal chemistry (2017): http://europepmc.org/abstract/med/28750311.
    10.1016/j.ejmech.2017.07.024
  29. Albini A; Bassani B; Baci D; Dallaglio K; Gallazzi M; Corradino P; Bruno A; Noonan DM. "Nutraceuticals and "repurposed" drugs of phytochemical origin in prevention and interception of chronic degenerative disease and cancer.". Current medicinal chemistry (2017): http://europepmc.org/abstract/med/28933290.
    10.2174/0929867324666170920144130
  30. Fabbri A; Cossa M; Sonzogni A; Bidoli P; Canova S; Cortinovis D; Abbate MI; et al. "Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.". Virchows Archiv : an international journal of pathology (2017): http://europepmc.org/abstract/med/28451756.
    10.1007/s00428-017-2130-2
  31. Grasso S; Chapelle J; Salemme V; Aramu S; Russo I; Vitale N; Verdun di Cantogno L; et al. "The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.". Nature communications (2017): http://europepmc.org/abstract/med/28300085.
    10.1038/ncomms14797
  32. Piroddi M; Albini A; Fabiani R; Giovannelli L; Luceri C; Natella F; Rosignoli P; et al. "Nutrigenomics of extra-virgin olive oil: A review.". BioFactors (Oxford, England) (2017): http://europepmc.org/abstract/med/27580701.
    10.1002/biof.1318
  33. Cristoni S; Dusi G; Brambilla P; Albini A; Conti M; Brambilla M; Bruno A; et al. "SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses.". Journal of mass spectrometry : JMS (2017): http://europepmc.org/abstract/med/27776380.
    10.1002/jms.3895
  34. Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K. "Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.". Oncotarget (2017): http://europepmc.org/abstract/med/28036292.
    10.18632/oncotarget.14321
  35. Gallo C; Dallaglio K; Bassani B; Rossi T; Rossello A; Noonan DM; D'Uva G; Bruno A; Albini A. "Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.". Oncotarget (2016): http://europepmc.org/abstract/med/27494895.
    10.18632/oncotarget.10990
  36. Albini A. "Extracellular Matrix Invasion in Metastases and Angiogenesis: Commentary on the Matrigel "Chemoinvasion Assay".". Cancer research (2016): http://europepmc.org/abstract/med/27528578.
    10.1158/0008-5472.can-16-1971
  37. Albini A; DeCensi A; Cavalli F; Costa A. "CANCER PREVENTION AND INTERCEPTION: A NEW ERA FOR CHEMOPREVENTIVE APPROACHES.". (2016): http://europepmc.org/abstract/med/27220959.
  38. Amaro, A.; Angelini, G.; Mirisola, V.; Esposito, A.I.; Reverberi, D.; Matis, S.; Maffei, M.; et al. "A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo". Oncotarget 7 42 (2016): 68803-68820. http://www.scopus.com/inward/record.url?eid=2-s2.0-85042071120&partnerID=MN8TOARS.
    10.18632/ONCOTARGET.11931
  39. Albini, A.. "Extracellular matrix invasion in metastases and angiogenesis: Commentary on the Matrigel "chemoinvasion assay"". Cancer Research 76 16 (2016): 4595-4597. http://www.scopus.com/inward/record.url?eid=2-s2.0-84982165878&partnerID=MN8TOARS.
    10.1158/0008-5472.CAN-16-1971
  40. Bassani, B.; Rossi, T.; De Stefano, D.; Pizzichini, D.; Corradino, P.; Macrì, N.; Noonan, D.M.; Albini, A.; Bruno, A.. "Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells". Journal of Functional Foods 27 (2016): 236-248. http://www.scopus.com/inward/record.url?eid=2-s2.0-84989170869&partnerID=MN8TOARS.
    10.1016/j.jff.2016.09.009
  41. Principi, E.; Girardello, R.; Bruno, A.; Manni, I.; Gini, E.; Pagani, A.; Grimaldi, A.; et al. "Systemic distribution of single-walled carbon nanotubes in a novel model: Alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo". International Journal of Nanomedicine 11 (2016): 4299-4316. http://www.scopus.com/inward/record.url?eid=2-s2.0-84985946860&partnerID=MN8TOARS.
    10.2147/IJN.S109950
  42. Albini, A.; DeCensi, A.; Cavalli, F.; Costa, A.. "Cancer prevention and interception: A new era for chemopreventive approaches". Clinical Cancer Research 22 17 (2016): 4322-4327. http://www.scopus.com/inward/record.url?eid=2-s2.0-84988632717&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-16-0695
  43. Talarico G; Orecchioni S; Dallaglio K; Reggiani F; Mancuso P; Calleri A; Gregato G; et al. "Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.". (2016): http://europepmc.org/abstract/med/26728433.
    10.1038/srep18673
  44. Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A. "Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/ß-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.". (2016): http://europepmc.org/abstract/med/27367907.
    10.1371/journal.pone.0154111
  45. Albini A; Briga D; Conti M; Bruno A; Farioli D; Canali S; Sogno I; et al. "SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers.". (2015): http://europepmc.org/abstract/med/26331920.
    10.1002/rcm.7270
  46. Albini A; Cavuto S; Apolone G; Noonan DM. "Strategies to Prevent "Bad Luck" in Cancer.". (2015): http://europepmc.org/abstract/med/26242894.
    10.1093/jnci/djv213
  47. Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; et al. "N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.". (2015): http://europepmc.org/abstract/med/26263024.
    10.1021/acs.jmedchem.5b00367
  48. Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; et al. "The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.". (2015): http://europepmc.org/abstract/med/25196138.
    10.1002/ijc.29193
  49. Fania C; Sogno I; Vasso M; Torretta E; Leone R; Bruno A; Consonni P; Albini A; Gelfi C. "A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification.". (2015): http://europepmc.org/abstract/med/25312866.
    10.1016/j.cca.2014.10.003
  50. Albini A; Pagani A; Pulze L; Bruno A; Principi E; Congiu T; Gini E; et al. "Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid deposition.". (2015): http://europepmc.org/abstract/med/26457053.
    10.2147/IJN.S85275
  51. Albini A; Bertolini F; Bassani B; Bruno A; Gallo C; Caraffi SG; Maramotti S; Noonan DM. "Biomarkers of cancer angioprevention for clinical studies.". (2015): http://europepmc.org/abstract/med/26635904.
    10.3332/ecancer.2015.600
  52. Focaccetti C; Bruno A; Magnani E; Bartolini D; Principi E; Dallaglio K; Bucci EO; et al. "Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes.". (2015): http://europepmc.org/abstract/med/25671635.
    10.1371/journal.pone.0115686
  53. Lococo F; Paci M; Rapicetta C; Rossi T; Sancisi V; Braglia L; Cavuto S; et al. "Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.". (2015): http://europepmc.org/abstract/med/26295387.
    10.3390/ijms160819612
  54. Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K. "Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.". (2015): http://europepmc.org/abstract/med/26291921.
    10.3109/03008207.2015.1066780
  55. Venè R; Cardinali B; Arena G; Ferrari N; Benelli R; Minghelli S; Poggi A; et al. "Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.". (2014): http://europepmc.org/abstract/med/25246272.
    10.1016/j.neo.2014.07.012
  56. Amaro A; Esposito AI; Gallina A; Nees M; Angelini G; Albini A; Pfeffer U. "Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel.". (2014): http://europepmc.org/abstract/med/24477410.
    10.1007/s10555-013-9470-4
  57. Bruno A; Ferlazzo G; Albini A; Noonan DM. "A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.". (2014): http://europepmc.org/abstract/med/25178695.
    10.1093/jnci/dju200
  58. Dallaglio K; Bruno A; Cantelmo AR; Esposito AI; Ruggiero L; Orecchioni S; Calleri A; et al. "Paradoxic effects of metformin on endothelial cells and angiogenesis.". (2014): http://europepmc.org/abstract/med/24419232.
    10.1093/carcin/bgu001
  59. Rossi, T.; Gallo, C.; Bassani, B.; Canali, S.; Albini, A.; Bruno, A.. "Drink your prevention: Beverages with cancer preventive phytochemicals". Polskie Archiwum Medycyny Wewnetrznej 124 12 (2014): 713-722. http://www.scopus.com/inward/record.url?eid=2-s2.0-84920055144&partnerID=MN8TOARS.
    10.20452/pamw.2560
  60. Rossi T; Gallo C; Bassani B; Canali S; Albini A; Bruno A. "Drink your prevention: beverages with cancer preventive phytochemicals.". (2014): http://europepmc.org/abstract/med/25490889.
  61. Amaro AA; Esposito AI; Mirisola V; Mehilli A; Rosano C; Noonan DM; Albini A; Pfeffer U; Angelini G. "Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells.". (2014): http://europepmc.org/abstract/med/23862621.
    10.2174/09298673113209990169
  62. Albini A; Rosano C; Angelini G; Amaro A; Esposito AI; Maramotti S; Noonan DM; Pfeffer U. "Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.". (2014): http://europepmc.org/abstract/med/24304271.
    10.2174/0929867321666131129124640
  63. Bruno A; Pagani A; Magnani E; Rossi T; Noonan DM; Cantelmo AR; Albini A. "Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention.". (2014): http://europepmc.org/abstract/med/24114493.
    10.1007/978-3-642-38007-5_23
  64. Bruno A; Pagani A; Pulze L; Albini A; Dallaglio K; Noonan DM; Mortara L. "Orchestration of angiogenesis by immune cells.". (2014): http://europepmc.org/abstract/med/25072019.
    10.3389/fonc.2014.00131
  65. Magnani E; Farnetti E; Nicoli D; Casali B; Savoldi L; Focaccetti C; Boni C; Albini A; Banzi M. "Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule.". (2013): http://europepmc.org/abstract/med/23585145.
    10.1007/s11739-013-0936-8
  66. Bruno A; Focaccetti C; Pagani A; Imperatori AS; Spagnoletti M; Rotolo N; Cantelmo AR; et al. "The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.". (2013): http://europepmc.org/abstract/med/23441128.
  67. Puccio G; Brambilla P; Conti M; Bartolini D; Noonan D; Albini A. "Surface-activated chemical ionization-electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid.". (2013): http://europepmc.org/abstract/med/23280980.
    10.1002/rcm.6471
  68. Bruno, A.; Focaccetti, C.; Pagani, A.; Imperatori, A.S.; Spagnoletti, M.; Rotolo, N.; Cantelmo, A.R.; et al. "The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer". Neoplasia (United States) 15 2 (2013): 133-142. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873501144&partnerID=MN8TOARS.
    10.1593/neo.121758
  69. Solinas M; Massi P; Cantelmo AR; Cattaneo MG; Cammarota R; Bartolini D; Cinquina V; et al. "Cannabidiol inhibits angiogenesis by multiple mechanisms.". (2012): http://europepmc.org/abstract/med/22624859.
    10.1111/j.1476-5381.2012.02050.x
  70. Albini A; Donatelli F; Focaccetti C; D'Elios MM; Noonan DM. "Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.". (2012): http://europepmc.org/abstract/med/22941411.
    10.1007/s11739-012-0845-2
  71. Croci DO; Salatino M; Rubinstein N; Cerliani JP; Cavallin LE; Leung HJ; Ouyang J; et al. "Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.". (2012): http://europepmc.org/abstract/med/23027923.
    10.1084/jem.20111665
  72. Albini A; Tosetti F; Li VW; Noonan DM; Li WW. "Cancer prevention by targeting angiogenesis.". (2012): http://europepmc.org/abstract/med/22850752.
    10.1038/nrclinonc.2012.120
  73. Tarantini L; Feola M; Albini A; Gori S; Foglietta J; Cicoira MA; Pulignano G. "[Heart failure in women treated with adjuvant trastuzumab for breast cancer].". (2012): http://europepmc.org/abstract/med/23678535.
  74. Sogno I; Conti M; Consonni P; Noonan DM; Albini A. "Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.". (2012): http://europepmc.org/abstract/med/22499197.
    10.1002/rcm.6208
  75. Albini A; Donatelli F; Noonan D; D'Elios MM; Prisco D. "Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology.". (2012): http://europepmc.org/abstract/med/22271393.
    10.1007/s11739-012-0756-2
  76. Albini A; Noonan DM. "Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy.". (2012): http://europepmc.org/abstract/med/22343030.
    10.1093/jnci/djs032
  77. Tarantini, L.; Feola, M.; Albini, A.; Gori, S.; Foglietta, J.; Cicoira, M.A.; Pulignano, G.. "Trastuzumab-induced heart failure in the treatment of breast cancer,Lo scompenso cardiaco da trastuzumab nel trattamento del tumore al seno". Giornale Italiano di Cardiologia 13 5 SUPPL. 1 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84867207314&partnerID=MN8TOARS.
    10.1714/1080.11830
  78. Ruggiero, L.; Sogno, I.; Focaccetti, C.; Bartolini, D.; Magnani, E.; Principi, E.; Noonan, D.M.; Albini, A.. "Effects of diet-derived molecules on the tumor microenvironment". Current Angiogenesis 1 3 (2012): 206-214. http://www.scopus.com/inward/record.url?eid=2-s2.0-84954081902&partnerID=MN8TOARS.
    10.2174/2211552811201030206
  79. Ferrari N; Tosetti F; De Flora S; Donatelli F; Sogno I; Noonan DM; Albini A. "Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention.". (2011): http://europepmc.org/abstract/med/21158708.
    10.2174/138945011798184227
  80. Albini A; Cesana E; Donatelli F; Cammarota R; Bucci EO; Baravelli M; Anzà C; Noonan DM. "Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.". (2011): http://europepmc.org/abstract/med/21929348.
    10.2217/fca.11.54
  81. Seo DW; Saxinger WC; Guedez L; Cantelmo AR; Albini A; Stetler-Stevenson WG. "An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo.". Peptides (2011): http://europepmc.org/abstract/med/21871510.
    10.1016/j.peptides.2011.08.010
  82. Baldanzi G; Pietronave S; Locarno D; Merlin S; Porporato P; Chianale F; Filigheddu N; et al. "Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells.". (2011): http://europepmc.org/abstract/med/21477072.
    10.1111/j.1349-7006.2011.01953.x
  83. Albini A; Cesana E; Noonan DM. "Cancer stem cells and the tumor microenvironment: soloists or choral singers.". (2011): http://europepmc.org/abstract/med/21044010.
    10.2174/138920111794295756
  84. Molteni, L.P.; Cergnul, M.; Scaglietti, U.; Noonan, D.M.; Bucci, E.O.; Gottardi, O.; Albini, A.. "Response to the letter to the Editor". Breast Journal 17 5 (2011): 566-567. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052564119&partnerID=MN8TOARS.
    10.1111/j.1524-4741.2011.01126.x
  85. Albini, A.; Donatelli, F.; Sessa, F.; Noonan, D.M.; Tosetti, F.. "Response". Journal of the National Cancer Institute 103 7 (2011): 608-609. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953885106&partnerID=MN8TOARS.
    10.1093/jnci/djr034
  86. Albini A; Noonan DM. "The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis.". (2010): http://europepmc.org/abstract/med/20822888.
    10.1016/j.ceb.2010.08.017
  87. Cantelmo AR; Cammarota R; Noonan DM; Focaccetti C; Comoglio PM; Prat M; Albini A. "Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.". Oncogene (2010): http://europepmc.org/abstract/med/20603611.
    10.1038/onc.2010.267
  88. Albini A; Indraccolo S; Noonan DM; Pfeffer U. "Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.". Clinical & experimental metastasis (2010): http://europepmc.org/abstract/med/20383568.
    10.1007/s10585-010-9312-5
  89. Albini A; Tímár J. "Genomics of metastatic progression.". Clinical & experimental metastasis (2010): http://europepmc.org/abstract/med/20711639.
    10.1007/s10585-010-9348-6
  90. Sogno I; Venè R; Ferrari N; De Censi A; Imperatori A; Noonan DM; Tosetti F; Albini A. "Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.". Critical reviews in oncology/hematology (2010): http://europepmc.org/abstract/med/20034809.
    10.1016/j.critrevonc.2009.10.007
  91. Albini A; Magnani E; Noonan DM. "The tumor microenvironment: biology of a complex cellular and tissue society.". The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. (2010): http://europepmc.org/abstract/med/20639811.
  92. Albini A; Mussi V; Parodi A; Ventura A; Principi E; Tegami S; Rocchia M; et al. "Interactions of single-wall carbon nanotubes with endothelial cells.". Nanomedicine : nanotechnology, biology, and medicine (2010): http://europepmc.org/abstract/med/19699323.
    10.1016/j.nano.2009.08.001
  93. Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM. "Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.". JNCI Journal of the National Cancer Institute (2010): http://europepmc.org/abstract/med/20007921.
    10.1093/jnci/djp440
  94. Garaventa, F.; Piazza, V.; Zovko, A.; Turk, T.; Chelossi, E.; Falugi, C.; Aluigi, M.G.; et al. "Multiple functions of the cholinesterase inhibiting polyalkylpyridinium salts extracted from the marine sponge, Haliclona sarai". WSEAS Transactions on Biology and Biomedicine 7 3 (2010): 103-113. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954721402&partnerID=MN8TOARS.
  95. Albini, A.; Magnani, E.; Noonan, D.M.. "The tumor microenvironment: Biology of a complex cellular and tissue society". Quarterly Journal of Nuclear Medicine and Molecular Imaging 54 3 (2010): 244-248. http://www.scopus.com/inward/record.url?eid=2-s2.0-77958555605&partnerID=MN8TOARS.
  96. Cammarota R; Bertolini V; Pennesi G; Bucci EO; Gottardi O; Garlanda C; Laghi L; et al. "The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker.". (2010): http://europepmc.org/abstract/med/21059221.
    10.1186/1479-5876-8-112
  97. Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A. "Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.". (2010): http://europepmc.org/abstract/med/21050310.
    10.1111/j.1524-4741.2010.01004.x
  98. López NC; Valck C; Ramírez G; Rodríguez M; Ribeiro C; Orellana J; Maldonado I; et al. "Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.". PLoS neglected tropical diseases (2010): http://europepmc.org/abstract/med/20625551.
    10.1371/journal.pntd.0000730
  99. Bachmeier BE; Mirisola V; Romeo F; Generoso L; Esposito A; Dell'eva R; Blengio F; et al. "Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin.". Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (2010): http://europepmc.org/abstract/med/20798532.
    10.1159/000320570
  100. Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M. "Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.". European cytokine network (2009): http://europepmc.org/abstract/med/20167562.
    10.1684/ecn.2009.0175
  101. Tosetti F; Noonan DM; Albini A. "Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals.". International journal of cancer (2009): http://europepmc.org/abstract/med/19551861.
    10.1002/ijc.24677
  102. Margheri F; Serratì S; Lapucci A; Anastasia C; Giusti B; Pucci M; Torre E; et al. "Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.". Neoplasia (New York, N.Y.) (2009): http://europepmc.org/abstract/med/19794969.
    10.1593/neo.09934
  103. Lorusso G; Vannini N; Sogno I; Generoso L; Garbisa S; Noonan DM; Albini A. "Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent.". European journal of cancer (Oxford, England : 1990) (2009): http://europepmc.org/abstract/med/19223175.
    10.1016/j.ejca.2009.01.014
  104. Wang E; Albini A; Stroncek DF; Marincola FM. "New take on comparative immunology: relevance to immunotherapy.". Immunotherapy (2009): http://europepmc.org/abstract/med/20635956.
    10.2217/imt.09.10
  105. Serratì S; Margheri F; Pucci M; Cantelmo AR; Cammarota R; Dotor J; Borràs-Cuesta F; et al. "TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis.". Biochemical pharmacology (2009): http://europepmc.org/abstract/med/19041849.
    10.1016/j.bcp.2008.10.036
  106. Abbadessa G; Accolla R; Aiuti F; Albini A; Aldovini A; Alfano M; Antonelli G; et al. "Unsung hero Robert C. Gallo.". Science (New York, N.Y.) (2009): http://europepmc.org/abstract/med/19131607.
    10.1126/science.323.5911.206
  107. Sogno, I.; Venè, R.; Sapienza, C.; Ferrari, N.; Tosetti, F.; Albini, A.; Sogno I; et al. "Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.". Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 181 (2009): 71-76. http://www.scopus.com/inward/record.url?eid=2-s2.0-61549090850&partnerID=MN8TOARS.
  108. Sogno, H.; Vannini, N.; Lorusso, G.; Cammarota, R.; Noonan, D.M.; Generoso, L.; Sporn, M.B.; et al. "Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.". Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 181 (2009): 209-212. http://www.scopus.com/inward/record.url?eid=2-s2.0-61549097189&partnerID=MN8TOARS.
  109. Albini A; Brigati C; Ventura A; Lorusso G; Pinter M; Morini M; Mancino A; Sica A; Noonan DM. "Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target.". Journal of translational medicine (2009): http://europepmc.org/abstract/med/19144161.
    10.1186/1479-5876-7-5
  110. Pfeffer U; Romeo F; Noonan DM; Albini A. "Prediction of breast cancer metastasis by genomic profiling: where do we stand?". Clinical & experimental metastasis (2009): http://europepmc.org/abstract/med/19308665.
    10.1007/s10585-009-9254-y
  111. Venè R; Larghero P; Arena G; Sporn MB; Albini A; Tosetti F. "Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids.". Cancer research (2008): http://europepmc.org/abstract/med/18757413.
    10.1158/0008-5472.can-07-6362
  112. Bianco R; Rosa R; Damiano V; Daniele G; Gelardi T; Garofalo S; Tarallo V; et al. "Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.". Clinical cancer research : an official journal of the American Association for Cancer Research (2008): http://europepmc.org/abstract/med/18694994.
    10.1158/1078-0432.ccr-07-4905
  113. Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; et al. "Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.". Clinical cancer research : an official journal of the American Association for Cancer Research (2008): http://europepmc.org/abstract/med/18628471.
    10.1158/1078-0432.ccr-08-0040
  114. Albini A; Mirisola V; Pfeffer U. "Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior.". Cancer metastasis reviews (2008): http://europepmc.org/abstract/med/18046511.
    10.1007/s10555-007-9111-x
  115. Albini A. "Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention.". Cancer metastasis reviews (2008): http://europepmc.org/abstract/med/18043872.
    10.1007/s10555-007-9102-y
  116. Araldi EM; Dell'aica I; Sogno I; Lorusso G; Garbisa S; Albini A. "Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer.". Current cancer drug targets (2008): http://europepmc.org/abstract/med/18336198.
    10.2174/156800908783769382
  117. Noonan DM; De Lerma Barbaro A; Vannini N; Mortara L; Albini A. "Inflammation, inflammatory cells and angiogenesis: decisions and indecisions.". Cancer metastasis reviews (2008): http://europepmc.org/abstract/med/18087678.
    10.1007/s10555-007-9108-5
  118. Bianco, R.; Rosa, R.; Damiano, V.; Daniele, G.; Gelardi, T.; Garofalo, S.; Tarallo, V.; et al. "Vascular endothelial growth factor receptor-1 contributes to resistance to anti - epidermal growth factor receptor drugs in human cancer cells". Clinical Cancer Research 14 16 (2008): 5069-5080. http://www.scopus.com/inward/record.url?eid=2-s2.0-52649143725&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-07-4905
  119. Monteghirfo, S.; Tosetti, F.; Ambrosini, C.; Stigliani, S.; Pozzi, S.; Frassoni, F.; Fassina, G.; et al. "Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-¿B and p53 modulation". Molecular Cancer Therapeutics 7 9 (2008): 2692-2702. http://www.scopus.com/inward/record.url?eid=2-s2.0-54049094848&partnerID=MN8TOARS.
    10.1158/1535-7163.MCT-08-0132
  120. Liby, K.; Risingsong, R.; Royce, D.B.; R. Williams, C.; Yore, M.M.; Honda, T.; Gribble, G.W.; et al. "Prevention and treatment of experimental estrogen receptor- negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268". Clinical Cancer Research 14 14 (2008): 4556-4563. http://www.scopus.com/inward/record.url?eid=2-s2.0-51649111044&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-08-0040
  121. Venè, R.; Larghero, P.; Arena, G.; Sporn, M.B.; Albini, A.; Tosetti, F.. "Glycogen synthase kinase 3ß regulates cell death induced by synthetic triterpenoids". Cancer Research 68 17 (2008): 6987-6996. http://www.scopus.com/inward/record.url?eid=2-s2.0-52049089207&partnerID=MN8TOARS.
    10.1158/0008-5472.CAN-07-6362
  122. Vannini N; Pfeffer U; Lorusso G; Noonan DM; Albini A. "Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model.". Current pharmaceutical design (2008): http://europepmc.org/abstract/med/18220832.
    10.2174/138161208783413248
  123. Miretti S; Roato I; Taulli R; Ponzetto C; Cilli M; Olivero M; Di Renzo MF; et al. "A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.". PloS one (2008): http://europepmc.org/abstract/med/18350164.
    10.1371/journal.pone.0001828
  124. Dell'Eva R; Ambrosini C; Vannini N; Piaggio G; Albini A; Ferrari N. "AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.". Cancer (2007): http://europepmc.org/abstract/med/17823911.
    10.1002/cncr.23017
  125. Albini A; Noonan DM; Ferrari N. "Molecular pathways for cancer angioprevention.". Clinical cancer research : an official journal of the American Association for Cancer Research (2007): http://europepmc.org/abstract/med/17671111.
    10.1158/1078-0432.ccr-07-0069
  126. Larghero P; Venè R; Minghelli S; Travaini G; Morini M; Ferrari N; Pfeffer U; et al. "Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.". Carcinogenesis (2007): http://europepmc.org/abstract/med/17127716.
    10.1093/carcin/bgl233
  127. Dell'Aica I; Niero R; Piazza F; Cabrelle A; Sartor L; Colalto C; Brunetta E; et al. "Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.". The Journal of pharmacology and experimental therapeutics (2007): http://europepmc.org/abstract/med/17289834.
    10.1124/jpet.106.116459
  128. Dell'Eva R; Ambrosini C; Minghelli S; Noonan DM; Albini A; Ferrari N. "The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway.". Carcinogenesis (2007): http://europepmc.org/abstract/med/16952909.
    10.1093/carcin/bgl162
  129. Secchiero P; Corallini F; Gonelli A; Dell'Eva R; Vitale M; Capitani S; Albini A; et al. "Antiangiogenic activity of the MDM2 antagonist nutlin-3.". Circulation research 100 1 (2007): 61-69. http://europepmc.org/abstract/med/17138942.
    10.1161/01.res.0000253975.76198.ff
  130. Venè R; Arena G; Poggi A; D'Arrigo C; Mormino M; Noonan DM; Albini A; et al. "Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications.". Molecular cancer therapeutics 6 1 (2007): 286-298. http://europepmc.org/abstract/med/17237288.
    10.1158/1535-7163.mct-06-0346
  131. Indraccolo S; Pfeffer U; Minuzzo S; Esposito G; Roni V; Mandruzzato S; Ferrari N; et al. "Identification of genes selectively regulated by IFNs in endothelial cells.". Journal of immunology (Baltimore, Md. : 1950) (2007): http://europepmc.org/abstract/med/17202376.
    10.4049/jimmunol.178.2.1122
  132. Albini, A.; Sporn, M.B.; Albini A; Sporn MB. "The tumour microenvironment as a target for chemoprevention". Nature Reviews Cancer 7 2 (2007): 139-147. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846531356&partnerID=MN8TOARS.
    10.1038/nrc2066
  133. Albini, A.; Noonan, D.M.; Ferrari, N.. "Molecular pathways for cancer angioprevention". Clinical Cancer Research 13 15 (2007): 4320-4325. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547683652&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-07-0069
  134. Vannini, N.; Lorusso, G.; Cammarota, R.; Barberis, M.; Noonan, D.M.; Sporn, M.B.; Albini, A.; et al. "The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent". Molecular Cancer Therapeutics 6 12 (2007): 3139-3146. http://www.scopus.com/inward/record.url?eid=2-s2.0-37549054326&partnerID=MN8TOARS.
    10.1158/1535-7163.MCT-07-0451
  135. Sporn, M.B.; Liby, K.; Yore, M.M.; Suh, N.; Albini, A.; Honda, T.; Sundararajan, C.; Gribble, G.W.. "Platforms and networks in triterpenoid pharmacology". Drug Development Research 68 4 (2007): 174-182. http://www.scopus.com/inward/record.url?eid=2-s2.0-36048944877&partnerID=MN8TOARS.
    10.1002/ddr.20179
  136. Bachmeier B; Nerlich AG; Iancu CM; Cilli M; Schleicher E; Vené R; Dell'Eva R; et al. "The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice.". Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (2007): http://europepmc.org/abstract/med/17310108.
    10.1159/000099202
  137. Noonan DM; Benelli R; Albini A; Noonan, D.M.; Benelli, R.; Albini, A.. "Angiogenesis and cancer prevention: a vision.". Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 174 (2007): 219-224. http://europepmc.org/abstract/med/17302199.
  138. Albini A; Benelli R. "The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation.". Nature protocols (2007): http://europepmc.org/abstract/med/17406614.
    10.1038/nprot.2006.466
  139. Albini A; Fassina G; Nicolò M; Dell'Eva R; Vené R; Cammarota R; Barberis M; Noonan DM. "Inhibition of a vascular ocular tumor growth by IL-12 gene transfer.". Clinical & experimental metastasis (2007): http://europepmc.org/abstract/med/17653825.
    10.1007/s10585-007-9085-7
  140. Paleari L; Trombino S; Falugi C; Gallus L; Carlone S; Angelini C; Sepcic K; et al. "Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors.". International journal of oncology 29 6 (2006): 1381-1388. http://europepmc.org/abstract/med/17088975.
  141. Tosetti F; Noonan DM; Albini A. "Choking hypoxia-inducible factor 1alpha: a novel mechanism for connective tissue growth factor inhibition of angiogenesis.". JNCI Journal of the National Cancer Institute (2006): http://europepmc.org/abstract/med/16849670.
    10.1093/jnci/djj294
  142. Albini A; Pfeffer U. "A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets.". Journal of the National Cancer Institute (2006): http://europepmc.org/abstract/med/16788148.
    10.1093/jnci/djj256
  143. Spinella F; Rosanò L; Decandia S; Di Castro V; Albini A; Elia G; Natali PG; Bagnato A. "Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.". Experimental biology and medicine (Maywood, N.J.) (2006): http://europepmc.org/abstract/med/16741061.
  144. Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; et al. "Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.". Molecular cancer therapeutics 5 6 (2006): 1483-1492. http://europepmc.org/abstract/med/16818507.
    10.1158/1535-7163.mct-06-0053
  145. Cantarella G; Risuglia N; Dell'eva R; Lempereur L; Albini A; Pennisi G; Scoto GM; Noonan DN; Bernardini R. "TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells.". British journal of cancer (2006): http://europepmc.org/abstract/med/16622457.
    10.1038/sj.bjc.6603092
  146. Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G. "Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.". FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2006): http://europepmc.org/abstract/med/16403733.
    10.1096/fj.05-5128fje
  147. Spinella, F.; Rosanò, L.; Decandia, S.; Di Castro, V.; Albini, A.; Elia, G.; Natali, P.G.; Bagnato, A.. "Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: Evidence for the endothelin-1 as a potential target". Experimental Biology and Medicine 231 6 (2006): 1123-1127. http://www.scopus.com/inward/record.url?eid=2-s2.0-33744902332&partnerID=MN8TOARS.
  148. Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G; et al. "The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.". International journal of immunopathology and pharmacology 19 1 (2006): 81-96. http://europepmc.org/abstract/med/16569346.
  149. Tettamanti G; Malagoli D; Benelli R; Albini A; Grimaldi A; Perletti G; Noonan DM; de Eguileor M; Ottaviani E. "Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.". Current medicinal chemistry (2006): http://europepmc.org/abstract/med/17073625.
    10.2174/092986706778521986
  150. Benelli R; Lorusso G; Albini A; Noonan DM. "Cytokines and chemokines as regulators of angiogenesis in health and disease.". Current pharmaceutical design (2006): http://europepmc.org/abstract/med/16918437.
    10.2174/138161206777947461
  151. Anfosso L; Efferth T; Albini A; Pfeffer U. "Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.". The pharmacogenomics journal (2006): http://europepmc.org/abstract/med/16432535.
    10.1038/sj.tpj.6500371
  152. Noonan DM; Brigati C; Dell'Eva R; Morini M; Minghelli S; Benelli R; Albini A. "Regulation of angiogenesis by angiostatin through immune cells and IL 12 production.". Retrovirology (2006): http://europepmc.org/abstract/PMC/PMC1716994.
  153. Albini A; Ferrari N; Tosetti F; Fassina G; Benelli R; Pfeffer U; Noonan D. "Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models.". Retrovirology (2006): http://europepmc.org/abstract/PMC/PMC1716979.
  154. Albini A; Tosetti F; Benelli R; Noonan DM; Albini, A.; Tosetti, F.; Benelli, R.; Noonan, D.M.. "Tumor inflammatory angiogenesis and its chemoprevention.". Cancer research 65 23 (2005): 10637-10641. http://europepmc.org/abstract/med/16322203.
    10.1158/0008-5472.can-05-3473
  155. Pfeffer U; Ferrari N; Dell'Eva R; Indraccolo S; Morini M; Noonan DM; Albini A. "Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses.". Mutation research (2005): http://europepmc.org/abstract/med/16084531.
    10.1016/j.mrfmmm.2005.04.014
  156. Timár J; Mészáros L; Orosz Z; Albini A; Rásó E. "WT1 expression in angiogenic tumours of the skin.". Histopathology (2005): http://europepmc.org/abstract/med/15982325.
    10.1111/j.1365-2559.2005.02169.x
  157. Albini A; Noonan DM. "Rescuing COX-2 inhibitors from the waste bin.". JNCI Journal of the National Cancer Institute (2005): http://europepmc.org/abstract/med/15928309.
    10.1093/jnci/dji149
  158. Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A. "The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.". Clinical cancer research : an official journal of the American Association for Cancer Research (2005): http://europepmc.org/abstract/med/15958647.
    10.1158/1078-0432.ccr-04-2210
  159. Bachmeier BE; Albini A; Vené R; Benelli R; Noonan D; Weigert C; Weiler C; et al. "Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.". Experimental cell research (2005): http://europepmc.org/abstract/med/15777790.
    10.1016/j.yexcr.2004.12.019
  160. Rossello A; Nuti E; Carelli P; Orlandini E; Macchia M; Nencetti S; Zandomeneghi M; et al. "N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.". Bioorganic & medicinal chemistry letters (2005): http://europepmc.org/abstract/med/15713379.
    10.1016/j.bmcl.2005.01.024
  161. Noonan DM; Severino A; Morini M; Tritarelli A; Manente L; D'Agnano I; Starace G; et al. "In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.". Journal of cellular physiology (2005): http://europepmc.org/abstract/med/15389561.
    10.1002/jcp.20182
  162. Ferrari, N.; Pfeffer, U.; Dell'Eva, R.; Ambrosini, C.; Noonan, D.M.; Albini, A.. "The transforming growth factor-ß family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl) retinamide". Clinical Cancer Research 11 12 (2005): 4610-4619. http://www.scopus.com/inward/record.url?eid=2-s2.0-20444432695&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-04-2210
  163. Margheri, F.; D'Alessio, S.; Serrati, S.; Pucci, M.; Del Rosso, A.; Benelli, R.; Ferrari, N.; et al. "The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: Role of HIV-Tat protein". International Journal of Oncology 27 1 (2005): 223-235. http://www.scopus.com/inward/record.url?eid=2-s2.0-24644509695&partnerID=MN8TOARS.
  164. Bachmeier, B.E.; Vené, R.; Iancu, C.M.; Pfeffer, U.; Mayer, B.; Noonan, D.; Albini, A.; et al. "Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines". Thrombosis and Haemostasis 93 4 (2005): 761-769. http://www.scopus.com/inward/record.url?eid=2-s2.0-16844375504&partnerID=MN8TOARS.
    10.1160/TH04-09-0601
  165. Sartor L; Pezzato E; Donà M; Dell'Aica I; Calabrese F; Morini M; Albini A; Garbisa S. "Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.". International journal of cancer (2004): http://europepmc.org/abstract/med/15386368.
    10.1002/ijc.20496
  166. Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T. "Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.". Biochemical pharmacology (2004): http://europepmc.org/abstract/med/15548382.
    10.1016/j.bcp.2004.08.021
  167. Forster-Horváth C; Mészáros L; Rásó E; Döme B; Ladányi A; Morini M; Albini A; Tímár J. "Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo.". Microvascular research (2004): http://europepmc.org/abstract/med/15313120.
    10.1016/j.mvr.2004.05.001
  168. Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A. "Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.". Clinical cancer research : an official journal of the American Association for Cancer Research (2004): http://europepmc.org/abstract/med/15269163.
    10.1158/1078-0432.ccr-03-0672
  169. Rossello A; Nuti E; Orlandini E; Carelli P; Rapposelli S; Macchia M; Minutolo F; et al. "New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).". Bioorganic & medicinal chemistry (2004): http://europepmc.org/abstract/med/15080939.
    10.1016/j.bmc.2004.01.047
  170. Scapini P; Morini M; Tecchio C; Minghelli S; Di Carlo E; Tanghetti E; Albini A; et al. "CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.". Journal of immunology (Baltimore, Md. : 1950) (2004): http://europepmc.org/abstract/med/15067085.
    10.4049/jimmunol.172.8.5034
  171. Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; et al. "Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.". Journal of neuroimmunology (2004): http://europepmc.org/abstract/med/14975595.
    10.1016/j.jneuroim.2003.11.021
  172. Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM. "Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.". Gene therapy (2004): http://europepmc.org/abstract/med/14737088.
    10.1038/sj.gt.3302175
  173. Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M. "AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.". Cancer gene therapy (2004): http://europepmc.org/abstract/med/14681728.
    10.1038/sj.cgt.7700657
  174. Fassina, G.; Venè, R.; Morini, M.; Minghelli, S.; Benelli, R.; Noonan, D.M.; Albini, A.. "Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate". Clinical Cancer Research 10 14 (2004): 4865-4873. http://www.scopus.com/inward/record.url?eid=2-s2.0-3242664189&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-03-0672
  175. Rásó, E.; Mészáros, L.; Albini, A.; Tímár, J.. "A WT1 Expressing Metastatic Human Kaposi Sarcoma Xenograft Model". Pathology and Oncology Research 10 1 (2004): 22-25. http://www.scopus.com/inward/record.url?eid=2-s2.0-1942536196&partnerID=MN8TOARS.
    10.1007/BF02893404
  176. Albini A; Benelli R; Noonan DM; Brigati C. "The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes.". The International journal of developmental biology (2004): http://europepmc.org/abstract/med/15349831.
    10.1387/ijdb.041822aa
  177. Rásó E; Mészáros L; Albini A; Tímár J. "A WT1 expressing metastatic human Kaposi sarcoma xenograft model.". Pathology oncology research : POR (2004): http://europepmc.org/abstract/med/15029257.
    10.1007/bf02893404
  178. Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A. "Inhibition of Kaposi's sarcoma in vivo by fenretinide.". Clinical cancer research : an official journal of the American Association for Cancer Research (2003): http://europepmc.org/abstract/med/14676128.
  179. Benelli R; Peissel B; Manenti G; Gariboldi M; Vanzetto C; Albini A; Dragani TA. "Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration.". Oncogene (2003): http://europepmc.org/abstract/med/14586397.
    10.1038/sj.onc.1207088
  180. Guenzi E; Töpolt K; Lubeseder-Martellato C; Jörg A; Naschberger E; Benelli R; Albini A; Stürzl M. "The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.". The EMBO journal (2003): http://europepmc.org/abstract/med/12881412.
    10.1093/emboj/cdg382
  181. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Albini A; Natali PG; Bagnato A; et al. "Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.". The American journal of pathology 163 2 (2003): 753-762. http://europepmc.org/abstract/med/12875994.
    10.1016/s0002-9440(10)63702-9
  182. Ferrari N; Palmisano GL; Paleari L; Basso G; Mangioni M; Fidanza V; Albini A; et al. "DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias.". Journal of leukocyte biology (2003): http://europepmc.org/abstract/med/12885948.
    10.1189/jlb.1102581
  183. Pezzato E; Donà M; Sartor L; Dell'Aica I; Benelli R; Albini A; Garbisa S. "Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate.". Journal of leukocyte biology (2003): http://europepmc.org/abstract/med/12832446.
    10.1189/jlb.0203086
  184. Pfeffer U; Noonan D; Albini A. "Re: Microarray studies challenge theories of metastasis.". JNCI Journal of the National Cancer Institute (2003): http://europepmc.org/abstract/med/12783940.
    10.1093/jnci/95.11.829
  185. Noonan DM; Gringeri A; Meazza R; Rosso O; Mazza S; Muça-Perja M; Le Buanec H; et al. "Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers.". Journal of acquired immune deficiency syndromes (1999) (2003): http://europepmc.org/abstract/med/12792355.
    10.1097/00126334-200305010-00008
  186. Giunti D; Borsellino G; Benelli R; Marchese M; Capello E; Valle MT; Pedemonte E; et al. "Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.". Journal of leukocyte biology (2003): http://europepmc.org/abstract/med/12714572.
    10.1189/jlb.1202598
  187. Florio T; Morini M; Villa V; Arena S; Corsaro A; Thellung S; Culler MD; et al. "Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.". Endocrinology (2003): http://europepmc.org/abstract/med/12639942.
    10.1210/en.2002-220949
  188. Donà M; Dell'Aica I; Calabrese F; Benelli R; Morini M; Albini A; Garbisa S. "Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.". Journal of immunology (Baltimore, Md. : 1950) (2003): http://europepmc.org/abstract/med/12682270.
    10.4049/jimmunol.170.8.4335
  189. Tosetti F; Venè R; Arena G; Morini M; Minghelli S; Noonan DM; Albini A. "N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death.". Molecular pharmacology (2003): http://europepmc.org/abstract/med/12606763.
    10.1124/mol.63.3.565
  190. Borghi R; Venè R; Arena G; Schubert D; Albini A; Tosetti F. "Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cells.". Journal of neurochemistry (2003): http://europepmc.org/abstract/med/12485405.
    10.1046/j.1471-4159.2003.01501.x
  191. Brigati, C.; Giacca, M.; Noonan, D.M.; Albini, A.; Brigati C; Giacca M; Noonan DM; Albini A. "HIV Tat, its TARgets and the control of viral gene expression". FEMS Microbiology Letters 220 1 (2003): 57-65. http://www.scopus.com/inward/record.url?eid=2-s2.0-0348087031&partnerID=MN8TOARS.
    10.1016/S0378-1097(03)00067-3
  192. Pfeffer, U.; Ferrari, N.; Morini, M.; Benelli, R.; Noonan, D.M.; Albini, A.. "Antiangiogenic activity of chemopreventive drugs". International Journal of Biological Markers 18 1 (2003): 70-74. http://www.scopus.com/inward/record.url?eid=2-s2.0-0142186748&partnerID=MN8TOARS.
    10.5301/JBM.2008.5042
  193. Ferrari, N.; Paleari, L.; Palmisano, G.L.; Tammaro, P.; Levi, G.; Albini, A.; Brigati, C.. "Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression". Oncology Reports 10 4 (2003): 973-977. http://www.scopus.com/inward/record.url?eid=2-s2.0-0346593258&partnerID=MN8TOARS.
  194. Benelli, R.; Morini, M.; Brigati, C.; Noonan, D.M.; Albini, A.. "Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.". International journal of oncology 22 1 (2003): 87-91. http://www.scopus.com/inward/record.url?eid=2-s2.0-1842858858&partnerID=MN8TOARS.
  195. Ferrari, N.; Morini, M.; Pfeffer, U.; Minghelli, S.; Noonan, D.M.; Albini, A.. "Inhibition of Kaposi's Sarcoma in Vivo by Fenretinide". Clinical Cancer Research 9 16 (2003): 6020-6029. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347995044&partnerID=MN8TOARS.
  196. Benelli R; Albini A; Noonan D. "Neutrophils and angiogenesis: potential initiators of the angiogenic cascade.". Chemical immunology and allergy (2003): http://europepmc.org/abstract/med/12947984.
    10.1159/000071560
  197. Bisacchi D; Benelli R; Vanzetto C; Ferrari N; Tosetti F; Albini A; Bisacchi, D.; et al. "Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives.". Cancer detection and prevention 27 3 (2003): 229-238. http://europepmc.org/abstract/med/12787731.
    10.1016/s0361-090x(03)00030-8
Livro
  1. Noonan, D.M.; Ventura, A.; Bruno, A.; Pagani, A.; Albini, A.. The angiogenic switch: Role of immune cells. 2011.
  2. Benelli, R.; Albini, A.; Noonan, D.. Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade. 2003.

Propriedade Intelectual

Patente
  1. Albini, Adriana. 2013. "“Olive mill waste water are antioxidant”".
  2. Albini, Adriana. 2013. "Synthetic Analogues of Xanthohumol".
Atividades

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2010 - Atual JNCI Journal of the National Cancer Institute (1460-2105) Oxford University Press
2010 - Atual Carcinogenesis (1460-2180) Oxford University Press
2010 - Atual Molecular Cancer Therapeutics (1538-8514) American Association for Cancer Research
2010 - Atual Clinical & Experimental Metastasis (1573-7276) Springer-Verlag

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2000/01/01 - Atual Dr. Albini is scientific reviewer for ERC (European Reasearch Council Executive Agency) Consolidator Grants, referee of AACR (American Association for Cancer Research) scientific awards and member of the Evaluation Committee for the ICREA (Catalan Institution for Research and Advanced Studies) ) Senior call. She was a member of the AIRC (Italian Association for Cancer Research) Technical Scientific Committee.

Entrevista (jornal / revista)

Descrição da atividade Jornal / Forum
2002 Dr. Albini is registered as a science journalist since December 2004. (card n ° 121630) Since February 1, 2020 she is Editor-in-chief of the English-language magazine "Cancerworld" From May 2003 to January 2015 she collaborated with "Salute" di Repubblica From November 2002 to February 2005 she collaborated regularly with "Il Secolo XIX" From November 2003 to June 2004 she edited the Sunday scientific editorial of "Repubblica" in Genoa She was a member of the Governing Council of UGIS (Union of Italian Scientific Journalists), 2014-2016

Membro de associação

Nome da associação Tipo de participação
2002/01/01 - Atual -President of the Technical Scientific Committee of O.N.Da (National Observatory on Women's Health) 2013-2017 - President of the Italian Society of Cancer Research (SIC) 2007-2009 - President of Metastasis Research Society (MRS) 2002-2004

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2015/01/01 - Atual -Board of Directors of AACR (American Association for Cancer Research) since 2018 -Member of the Technical Health Committee for Health Research Section of the Ministry of Health since 2018 -Member of the Scientific Committee of ESO (European School of Oncology) since 2017 -Member of the IBSA Foundation for Scientific Research Advisory Board since 2017 -Member of the Technical Scientific Committee of O.N.Da (National Observatory on Women's Health) since 2017 -Member of the Scientific Committee of the Edo Tempia Fund for the fight against cancer
Distinções

Prémio

2019 "Sesto d'Oro" Civic Merit
2018 "Venetian of the year" Award
2016 “TWIS”- Top Italian Women Scientists, Luigi Castagnetta Award in Oncology Research
2015 UWIIN International (EUWIIN is the European Union Women Inventors & Innovators Network)
2013 ITWIIN Award for High Education in Science (ITWIIN is the Italian Women Inventors and Innovators Network)
2010 Ippocrate Award Section “Research”
2007 Berlucchi Research Award
2000 Florence Women Award (Firenze Donna) for the sector of Scientific Research
1987 Doerenkamp Zbinden/John's-Hopkins for research